BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 20595389)

  • 1. MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment.
    Marchese FP; Aubareda A; Tudor C; Saklatvala J; Clark AR; Dean JL
    J Biol Chem; 2010 Sep; 285(36):27590-600. PubMed ID: 20595389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment.
    Clement SL; Scheckel C; Stoecklin G; Lykke-Andersen J
    Mol Cell Biol; 2011 Jan; 31(2):256-66. PubMed ID: 21078877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Conserved CNOT1 Interaction Motif of Tristetraprolin Regulates ARE-mRNA Decay Independently of the p38 MAPK-MK2 Kinase Pathway.
    Carreño A; Lykke-Andersen J
    Mol Cell Biol; 2022 Sep; 42(9):e0005522. PubMed ID: 35920669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
    Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
    Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan-Mediated Interactions between Tristetraprolin and the CNOT9 Subunit Are Required for CCR4-NOT Deadenylase Complex Recruitment.
    Bulbrook D; Brazier H; Mahajan P; Kliszczak M; Fedorov O; Marchese FP; Aubareda A; Chalk R; Picaud S; Strain-Damerell C; Filippakopoulos P; Gileadi O; Clark AR; Yue WW; Burgess-Brown NA; Dean JLE
    J Mol Biol; 2018 Mar; 430(5):722-736. PubMed ID: 29291391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of mRNA decay by phosphorylation of tristetraprolin.
    Sandler H; Stoecklin G
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):491-6. PubMed ID: 18481987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tristetraprolin deadenylation by poly(A) binding protein.
    Rowlett RM; Chrestensen CA; Schroeder MJ; Harp MG; Pelo JW; Shabanowitz J; DeRose R; Hunt DF; Sturgill TW; Worthington MT
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G421-30. PubMed ID: 18467502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay.
    Stoecklin G; Stubbs T; Kedersha N; Wax S; Rigby WF; Blackwell TK; Anderson P
    EMBO J; 2004 Mar; 23(6):1313-24. PubMed ID: 15014438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin.
    Sandler H; Kreth J; Timmers HT; Stoecklin G
    Nucleic Acids Res; 2011 May; 39(10):4373-86. PubMed ID: 21278420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure/function analysis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function.
    Rigby WF; Roy K; Collins J; Rigby S; Connolly JE; Bloch DB; Brooks SA
    J Immunol; 2005 Jun; 174(12):7883-93. PubMed ID: 15944294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation.
    Tiedje C; Ronkina N; Tehrani M; Dhamija S; Laass K; Holtmann H; Kotlyarov A; Gaestel M
    PLoS Genet; 2012 Sep; 8(9):e1002977. PubMed ID: 23028373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin.
    Ronkina N; Menon MB; Schwermann J; Tiedje C; Hitti E; Kotlyarov A; Gaestel M
    Biochem Pharmacol; 2010 Dec; 80(12):1915-20. PubMed ID: 20599781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38 Mitogen-activated protein kinase stabilizes mRNAs that contain cyclooxygenase-2 and tumor necrosis factor AU-rich elements by inhibiting deadenylation.
    Dean JL; Sarsfield SJ; Tsounakou E; Saklatvala J
    J Biol Chem; 2003 Oct; 278(41):39470-6. PubMed ID: 12882963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK2 posttranscriptionally regulates TNF-α-induced expression of ICAM-1 and IL-8 via tristetraprolin in human pulmonary microvascular endothelial cells.
    Shi JX; Su X; Xu J; Zhang WY; Shi Y
    Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(8):L793-9. PubMed ID: 22268119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPK p38 regulates inflammatory gene expression via tristetraprolin: Doing good by stealth.
    O'Neil JD; Ammit AJ; Clark AR
    Int J Biochem Cell Biol; 2018 Jan; 94():6-9. PubMed ID: 29128684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways.
    Brook M; Tchen CR; Santalucia T; McIlrath J; Arthur JS; Saklatvala J; Clark AR
    Mol Cell Biol; 2006 Mar; 26(6):2408-18. PubMed ID: 16508015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding.
    Chrestensen CA; Schroeder MJ; Shabanowitz J; Hunt DF; Pelo JW; Worthington MT; Sturgill TW
    J Biol Chem; 2004 Mar; 279(11):10176-84. PubMed ID: 14688255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade.
    Ehlting C; Lai WS; Schaper F; Brenndörfer ED; Matthes RJ; Heinrich PC; Ludwig S; Blackshear PJ; Gaestel M; Häussinger D; Bode JG
    J Immunol; 2007 Mar; 178(5):2813-26. PubMed ID: 17312125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
    Yego EC; Dillman JF
    Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells.
    Lee S; Micalizzi D; Truesdell SS; Bukhari SIA; Boukhali M; Lombardi-Story J; Kato Y; Choo MK; Dey-Guha I; Ji F; Nicholson BT; Myers DT; Lee D; Mazzola MA; Raheja R; Langenbucher A; Haradhvala NJ; Lawrence MS; Gandhi R; Tiedje C; Diaz-Muñoz MD; Sweetser DA; Sadreyev R; Sykes D; Haas W; Haber DA; Maheswaran S; Vasudevan S
    Genome Biol; 2020 Feb; 21(1):33. PubMed ID: 32039742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.